Therapeutic Outcomes of Selective Serotonin Reuptake Inhibitors and Phosphodiesterase-5 Inhibitors Combination Therapy Versus Monotherapy
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Ebtehal Alaa El-Din Kotop Mohamed, Lecturer
Dermatology, venereology and andrology ,Qena Faculty of medicine ,south valley university.
Study Director - Mostafa Adam Ali El-Taib, Professor
Dermatology, venereology and andrology ,Qena Faculty of medicine ,south valley university.
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- South Valley University Hospital
Qina, Egypt
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Jul 2025
- Primary completion
- 1 Feb 2026
- Completion
- 10 Feb 2026
- Last update posted
- 9 Jul 2025
- Registered enrollment
- 60
- Registry id
- NCT07057011
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.